JAZZ vs EXEL
Jazz Pharmaceuticals vs Exelixis — AI-powered side-by-side comparison
| Metric | JAZZ | EXEL |
|---|---|---|
| AI Score | 55 | 63 |
| Price | $252.54 | $53.05 |
| P/E Ratio | 616.73× | 17.00× |
| ROE | -0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 1.0% |
| Debt / Equity | 1.20× | 0.09× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 53.1 | 31.9 |
| Beta | 0.324 | 0.424 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
JAZZ Full Analysis
EXEL Full Analysis